Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
MaSTherCell
MaSTherCell
Activities:
Manufacturing
Pharmaceutical
Cell & Gene Therapy
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery
The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
ISPE announces 2024 Facility of the Year Awards category winners
The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Manufacturing
Catalent adds to regenerative therapy portfolio with $315m acquisition
Belgian CDMO MaSTherCell Global is a technology-focused cell and gene therapy CDMO
Manufacturing
MaSTherCell announces new cell and gene therapy facility in Belgium
The new facility will be built to manufacture late-stage and commercially-approved cell and gene therapy products on the Gosselies Biopark site
Estates & Facilities
Biotech manufacturing services agreement in Europe announced
MaSTherCell will manufacture tumour infiltrating lymphocyte for Iovance’s European late-stage clinical trials
Research & Development
CRISPR Therapeutics and MaSTherCell SA develop allogeneic cell therapies
CRISPR Therapeutics and MaSTherCell SA sign an agreement to develop and manufacture allogeneic CAR-T therapies
Manufacturing
Servier appoints MaSTherCell to develop its cell therapy manufacturing platform
MaSTherCell is developing CAR-T cell therapy manufacturing platform, enabling industrial manufacturing of Servier products
Manufacturing
TxCell signs strategic agreement with MaSTherCell to manufacture cell therapy products
Company commits to an ambitious product development schedule with two discovery platforms
Finance
Orgenesis acquires cell therapy manufacturer MaSTherCell
Acquisition to accelerate type 1 diabetes therapeutic into clinical trials and diversify future business model and product offering
Subscribe now